Evaluating Health Research Funding in Ireland

Assessing the Impacts of the Health Research Board of Ireland's Funding Activities

Published in: Research Evaluation, v. 20, no. 3, Sep. 2011, p. 193-200

Posted on RAND.org on September 01, 2011

by Edward Nason, Brendan Curran, Stephen Hanney, Barbara Janta, Gillian Hastings, Mairead O'Driscoll, Steven Wooding

Read More

Access further information on this document at Research Evaluation

This article was published outside of RAND. The full text of the article can be found at the link above.

Understanding the impact of research is important for funding bodies in accounting for funds, advocating additional resources and learning how better to achieve their aims. The Health Research Board (HRB) has funded research in Ireland for over 20 years. We analysed eight examples of HRB grants from between 10 and 15 years earlier using the Payback Framework to catalogue the impacts. They ranged from world-class academic articles and new clinical assays through to improvements in recovery time for acute myocardial infarction and development of a drug company worth over €5 million. Here we first describe the study, then examine the role of the Payback Framework in research impact assessment including examining impacts made by the HRB study itself following its completion in 2008. We discuss how that study has contributed to further development of research impact assessment methods that could be used by the HRB and others.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.